Myrobalan raises early VC round to bring central nervous system drug into clinic

A Medford biotech developing an oral drug to repair damage and restore neural function in patients with such conditions as Alzheimer ’s disease and multiple sclerosis has raised a round of venture capital.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 10, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news